`
Lynparza shows positive result in pancreatic cancer study
Pharma/BioPharma | News | 0 Comment | 27 Feb, 2019
AstraZeneca and Merck announced positive results from the Phase III POLO trial. Results showed a statistically-significant and clinically-meaningful improvement in progression-free survival...Read more
Glenmark announces results from new analysis on Ryaltris™
Pharma/BioPharma | News | 0 Comment | 26 Feb, 2019
Ryaltris (olopatadine hydrochloride [665 mcg] and mometasone furoate [25 mcg]), formerly GSP 301 Nasal Spray, is the company’s leading respiratory pipeline asset and currently under r...Read more
Dr Reddy's re-launches Buprenorphine, Naloxone Sublingual Film
Pharma/BioPharma | News | 0 Comment | 21 Feb, 2019
Dr. Reddy’s Laboratories Ltd. has announced the re-launch of its Buprenorphine and Naloxone Sublingual Film, 2 mg/0.5 mg, 4 mg/1 mg, 8 mg/2 mg, and 12 mg/3 mg, a therapeutic equivalen...Read more
Glenmark to present new analysis on Ryaltris at the AAAAI 2019
Pharma/BioPharma | News | 0 Comment | 20 Feb, 2019
Glenmark Pharmaceuticals has announced upcoming presentations of pooled data from clinical studies of Ryaltris™ (olopatadine hydrochloride [665 mcg] and mometasone furoate [25 mcg]), ...Read more
India Ratings and Research maintains a stable outlook on the Indian pharmaceutical sector
Pharma/BioPharma | Reports/white papers | 0 Comment | 19 Feb, 2019
India Ratings and Research (Ind-Ra) has maintained a stable outlook on the Indian pharmaceutical sector due to the expected recovery in margins, improved cash generation on the back of emer...Read more
Orit Lab gets USFDA nod for Fenofibrate Tablets
Pharma/BioPharma | News | 0 Comment | 18 Feb, 2019
Alembic Pharmaceuticals Limited (Alembic) has announced that its wholly owned step down subsidiary Orit Laboratories LLC has received approval from the US Food & Drug Administration (US...Read more
Glenmark receives ANDA approval for Clobetasol Propionate Foam
Pharma/BioPharma | News | 0 Comment | 18 Feb, 2019
Glenmark Pharmaceuticals has been granted final approval by the United States Food & Drug Administration (U.S. FDA) for Clobetasol Propionate Foam, 0.05%, a generic version of Olux®...Read more
Lupin launches Clobazam Oral Suspension to treat seizures
Pharma/BioPharma | News | 0 Comment | 18 Feb, 2019
Pharma major Lupin has announced the launch of Clobazam Oral Suspension, 2.5mg/mL, having received an approval from the United States Food and Drug Administration (FDA) earlier. Lupin&rsqu...Read more
Glenmark to spin off its innovation business in US
Pharma/BioPharma | News | 0 Comment | 15 Feb, 2019
Glenmark Pharmaceuticals has announced that its Board of Directors has given an in-principle approval to spin off the innovation business into a new company in the US. Setting up of the ne...Read more
Jubilant Biosys collaborates with Sanofi in CNS therapeutic area
Pharma/BioPharma | News | 0 Comment | 14 Feb, 2019
Jubilant Biosys, a Bengaluru-based subsidiary of Jubilant Life Sciences has announced a new integrated drug discovery collaboration with Sanofi in the CNS therapeutic area. The first colla...Read more
Aurobindo completes acquisition of Apotex’s five European Biz
Pharma/BioPharma | News | 0 Comment | 13 Feb, 2019
Aurobindo Pharma Limited, a world-leading marketer and manufacturer of generic pharmaceuticals and active pharmaceutical ingredients, has announced that it has closed the acquisition of Apo...Read more
Zydus receives USFDA approval for anticonvulsant drug
Pharma/BioPharma | News | 0 Comment | 12 Feb, 2019
Zydus Cadila has received the final approval from the USFDA to market Carbamazepine Extended-Release Tablets USP (US RLD – Tegretol XR), 100 mg, 200 mg, and 400 mg. It will be manufac...Read more
IPA urges USTR for removal of India from Priority Watch List
Pharma/BioPharma | News | 0 Comment | 11 Feb, 2019
IPA has drawn the attention of the USTR to the rapid progress made by India on a number of fronts which were cited by the USTR while placing India on the Priority Watch List in 2018. The 2...Read more
Alkermes announces rejection of ALKS 5461 NDA
Pharma/BioPharma | News | 0 Comment | 04 Feb, 2019
Alkermes plc has announced that it received a Complete Response Letter (CRL) from the U.S. Food and Drug Administration (FDA) regarding its New Drug Application (NDA) for ALKS 5461 fo...Read more
Natco Pharma submits ANDA for Ibrutinib generic
Pharma/BioPharma | News | 0 Comment | 01 Feb, 2019
Natco Pharma Limited has announced submission of an Abbreviated New Drug Application (ANDA) containing a paragraph IV certification with the U.S. Food and Drug Administration (FDA) for gene...Read more
Strides to acquire full stake in Vensun Pharma
Pharma/BioPharma | News | 0 Comment | 30 Jan, 2019
Strides Pharma Science Limited has announced that its step down subsidiary Strides Pharma, Inc has entered into an arrangement to acquire 100 per cent stake in Vensun Pharmaceuticals, Inc, ...Read more
Dr Reddy's receives FDA approval for nasal spray in US
Pharma/BioPharma | News | 0 Comment | 28 Jan, 2019
Dr. Reddy’s Laboratories Ltd. and its subsidiary, Promius Pharma, LLC have announced the approval of TOSYMRA (previously known as DFN-02) by the U.S. Food and Drug Administration (FDA...Read more
Olon S.p.A. expands globally by acquiring Capua BioServices
Pharma/BioPharma | News | 0 Comment | 28 Jan, 2019
Olon S.p.A., a world leading Active Pharmaceutical Ingredients (API) contract development and manufacturing organization (CDMO) and generics supplier, has announced the acquisition of Capua...Read more